查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1917782

消毒剂和清洁剂市场－2026-2031年预测

Antiseptic and Disinfectant Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计消毒剂和清洁剂市场将从 2025 年的 414.63 亿美元成长到 2031 年的 583.8 亿美元，复合年增长率为 5.87%。

消毒剂和清洁剂市场正经历强劲成长，这主要得益于医疗机构对酒精类消毒剂需求的不断增长。医疗机构正在加强消毒剂的使用力度，以遏制医院感染（HAI）。製造商正投入大量研发资源，开发先进的频谱消毒解决方案。保险公司扩大报销范围的政策也使全球消毒剂的普及程度不断提高。

消毒剂的作用机转和应用范围与抗生素不同，可提供频谱抗菌活性，适用于局部和表面处理。儘管目前证据有限，但消毒剂的广泛使用引发了关于微生物抗药性潜在风险的持续争论。预防感染的需求、监管机构对卫生问题的重视以及製剂功效的创新推动了市场的稳定成长。

感染发生率的上升是成长要素，因此需要在各个层面采取强有力的预防措施。由于卫生和预防措施不力，医院获得性感染（HAI）的增加凸显了消毒剂和清洁剂在污染控制和减少感染传播方面的重要性。优惠的报销方案正在刺激先进产品的采用，使其价格更加亲民，即使在经济条件有限的情况下也能负担得起。表面消毒剂，例如次氯酸钠和高浓度酒精，在惰性环境消毒方面展现出显着的潜力。医疗设备消毒剂利用过氧化氢、过氧乙酸和戊二醛等化合物，满足内视镜和手术器械的再处理需求。随着手术数量的增加，它们有助于防止患者之间的交叉感染。由于酒精类产品能够快速、无毒地杀死包括细菌、病毒和真菌在内的多种病原体，因此在器械消毒方面越来越受欢迎。

由于医护人员数量不断增加、外科手术量上升以及医院感染（HAI）的普遍存在，预计北美将引领市场。该地区对感染治疗的重视和严格的卫生通讯协定正在推动市场需求。

总体而言，市场正经历强劲成长，这得益于感染控制的优先事项、报销支援以及表面、设备和酒精类解决方案等细分领域的进步，从而使消毒剂和清洁剂成为安全临床实践和公共卫生韧性的基础要素。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
  • 市场驱动因素与未来趋势：探索市场驱动因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在快速变化的环境中做出策略决策，并发现新的商机和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

企业如何使用我们的报告？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

研究范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 按类型分類的消毒剂和清洁剂市场

  • 介绍
  • 季铵化合物
  • 氯基化合物
  • 醇和醛类产品
  • 酵素
  • 其他的

6. 按产品分類的消毒剂和清洁剂市场

  • 介绍
  • 酵素性清洁剂
  • 医疗设备消毒剂
  • 表面消毒剂

7. 按最终用户分類的消毒剂和清洁剂市场

  • 介绍
  • 医院
  • 诊所
  • 其他的

8. 按地区分類的消毒剂和清洁剂市场

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • PSK Pharma
  • ACTO GmbH
  • Dr. Schumacher GmbH
  • 3M
  • Reckitt Benckiser
  • Steris Plc
  • Kimberly-Clark Corporation
  • Cardinal Health
  • BD

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615753

Antiseptic And Disinfectant Market, growing at a 5.87% CAGR, is expected to grow to USD 58.38 billion in 2031 from USD 41.463 billion in 2025.

The antiseptic and disinfectant market is witnessing strong growth, driven by heightened demand for alcohol-based disinfectants in clinical environments. Healthcare facilities are intensifying antiseptic usage to curb hospital-acquired infections (HAIs). Manufacturers are committing substantial R&D resources to formulate advanced, broad-spectrum solutions. Reimbursement policies from insurers are broadening access to disinfectant treatments worldwide.

Antiseptics and disinfectants provide broad-spectrum antimicrobial activity for topical and surface applications, distinct from antibiotics in mechanism and scope. Extensive use has sparked ongoing discussions regarding potential microbial resistance development, though evidence remains limited. The market is expanding steadily, supported by infection prevention imperatives, regulatory emphasis on hygiene, and innovation in formulation efficacy.

Key growth drivers include rising infection incidence, necessitating robust preventive measures across populations. Escalating HAIs, stemming from lapses in sanitation and precautions, underscore the critical role of antiseptics and disinfectants in contamination control and transmission reduction. Attractive reimbursement frameworks enhance affordability, encouraging adoption of advanced products despite economic constraints. Surface disinfectants demonstrate notable potential, employing agents like sodium hypochlorite and high-concentration alcohols for inert environment sanitization. Medical device disinfectants, utilizing compounds such as hydrogen peroxide, peracetic acid, and glutaraldehyde, address reprocessing needs for endoscopes and surgical tools to prevent cross-patient contamination amid increasing procedural volumes. Alcohol-based variants are gaining traction for instrument disinfection due to rapid, non-toxic action against diverse pathogens, including bacteria, viruses, and fungi.

Geographically, North America is anticipated to lead, fueled by expanding healthcare workforce, rising surgical volumes, and heightened HAI prevalence. The region's focus on infection therapies and stringent hygiene protocols amplifies demand.

Overall, the market is progressing robustly, anchored in infection control priorities, reimbursement support, and segment-specific advancements in surface, device, and alcohol-based solutions, positioning antiseptics and disinfectants as foundational to safe clinical practice and public health resilience.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Antiseptic and Disinfectant Market Segmentation

  • By Type
  • Quaternary Ammonium Compounds
  • Chlorine Compounds
  • Alcohols & Aldehyde Products
  • Enzyme
  • Others
  • By Product
  • Enzymatic Cleaners
  • Medical Device Disinfectants
  • Surface Disinfectants
  • By End-User
  • Hospitals
  • Clinics
  • Others
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ANTISEPTIC AND DISINFECTANT MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Quaternary Ammonium Compounds
  • 5.3. Chlorine Compounds
  • 5.4. Alcohols & Aldehyde Products
  • 5.5. Enzyme
  • 5.6. Others

6. ANTISEPTIC AND DISINFECTANT MARKET BY PRODUCT

  • 6.1. Introduction
  • 6.2. Enzymatic Cleaners
  • 6.3. Medical Device Disinfectants
  • 6.4. Surface Disinfectants

7. ANTISEPTIC AND DISINFECTANT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Clinics
  • 7.4. Others

8. ANTISEPTIC AND DISINFECTANT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. PSK Pharma
  • 10.2. ACTO GmbH
  • 10.3. Dr. Schumacher GmbH
  • 10.4. 3M
  • 10.5. Reckitt Benckiser
  • 10.6. Steris Plc
  • 10.7. Kimberly-Clark Corporation
  • 10.8. Cardinal Health
  • 10.9. BD

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations